tm logo
BELDEVI
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 02 Jan 2023

Last Applicant/ Owned by

Laxmi Towers

Mumbai

IN

400051

Serial Number

88662090 filed on 21st Oct 2019

Registration Number

N/A

Correspondent Address

Robert L. Powley

POWLEY & GIBSON, P.C.

SUITE 2203

60 HUDSON STREET

NEW YORK NY 10013

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

BELDEVI

pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation; tranRead More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation; transdermal adhesive patches containing contraceptive preparations

Mark Details


Serial Number

No 88662090

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 390.49(US-4)

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Jan 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02th Jan 2023ABANDONMENT - NO USE STATEMENT FILED
04th Jun 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03rd Jun 2022SOU EXTENSION 4 GRANTED
03rd Jun 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
26th May 2022SOU EXTENSION 4 FILED
26th May 2022TEAS EXTENSION RECEIVED
30th Nov 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26th Nov 2021SOU EXTENSION 3 GRANTED
26th Nov 2021SOU EXTENSION 3 FILED